What businesses need to know about selling cosmetics in Singapore
Non-compliance with HSA regulations can result in penalties.
Companies in Singapore involved in manufacturing, importing, or selling cosmetics must comply with regulations set by the Health Sciences Authority (HSA) under the ASEAN Cosmetic Directive (ACD), according to Dentons Rodyk.
The city-state's beauty and personal care market reached $1.24b in 2024, with cosmetic product demand steadily increasing.
Companies involved in manufacturing, importing, or selling cosmetics must comply with regulations set by the Health Sciences Authority (HSA) under the ASEAN Cosmetic Directive (ACD).
The Health Products Act 2007 (HPA) defines a "cosmetic product" as any substance or preparation intended for use on the skin, hair, nails, or lips for cleaning, perfuming, altering appearance, or maintaining good condition. Products claiming therapeutic effects are classified as "therapeutic products" and face stricter controls.
To sell a cosmetic product in Singapore, the "person responsible"—defined as the entity instrumental in making the product available in the market—must submit a cosmetic product notification to the HSA. This applies to manufacturers, importers, distributors, or retailers. The notification must include product details, necessary documents, and payment of fees, which vary based on the product's risk level. Higher-risk products, such as eye or lip products and hair dyes containing phenylenediamines, are subject to higher fees. Notifications are valid for one year and require annual re-notification.
Sellers are legally responsible for ensuring the safety, quality, and truthful representation of cosmetic products. They must adhere to specific regulations concerning prohibited and restricted substances, such as hydroquinone and mercury, which are banned or restricted in cosmetics under the Health Products Regulations 2007.
Labels must also display the product name, function, ingredient list, usage precautions, and expiry date for products with a shelf life under 30 months. All information must be in English and clearly legible.
Additionally, advertisements must not falsely claim therapeutic benefits or mislead consumers about product quality or safety.
Non-compliance with HSA regulations can result in penalties, product recalls, and reputational damage. Companies are advised to stay updated on regulatory changes and seek legal advice to ensure compliance and mitigate risks.